Flubrotizolam
CAS: 57801-95-3
Category: Organic Intermediates
| Purity | Research Grade ≥98%, High-Purity Grade ≥99%, Analytical Reference Standard ≥99.5% |
| Molecular Formula | C15H10BrFN4S |
| Molecular Weight | 377.23 |
| Appearance | White to off-white crystalline powder |
| Packaging | 100mg/500mg/1g/5g/10g/foil bag or plastic bottle (for research purposes) |
| Testing Indicators | Appearance — Visual inspection; Identification — NMR (¹H, ¹³C), FTIR, or LC-MS/MS; Purity — HPLC (C18 column, UV detection at 220–254 nm); Melting point — Capillary method; Residual solvents — GC; Heavy metals — ICP-MS; Loss on drying — Gravimetry; Water content — Karl Fischer titration; Related substances (impurities, degradation products) — HPLC; Mass verification — High-resolution mass spectrometry (HRMS). |
| Storage Notes | Stored in a tightly sealed container in a cool, dry, well-ventilated area, protected from light and moisture, away from incompatible materials, heat, and direct sunlight; store under inert atmosphere for long-term stability; classified as a controlled substance in many jurisdictions. |
| Lead Time | days |
Used as a research chemical in pharmacological studies; a thienotriazolodiazepine derivative structurally related to brotizolam; acts as a positive allosteric modulator of the GABAA receptor (benzodiazepine site), producing sedative, hypnotic, anxiolytic, muscle relaxant, and anticonvulsant effects; used in structure-activity relationship studies of benzodiazepine receptor ligands; not approved for medical use in humans (research use only).